Immunic Appoints Jon Congleton To Board
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced the appointment... Read More
The post Immunic Appoints Jon Congleton To Board appeared first on citybiz.